California 2019-2020 Regular Session

California Assembly Bill AB715

Introduced
2/19/19  
Refer
2/28/19  
Refer
2/28/19  
Report Pass
4/3/19  
Report Pass
4/3/19  
Refer
4/3/19  
Refer
5/15/19  
Refer
5/15/19  
Report Pass
5/16/19  
Report Pass
5/16/19  
Engrossed
5/29/19  
Engrossed
5/29/19  
Refer
5/30/19  
Refer
5/30/19  
Refer
6/12/19  
Refer
6/12/19  
Report Pass
6/24/19  
Report Pass
6/24/19  
Refer
6/24/19  
Refer
6/24/19  
Report Pass
7/10/19  
Report Pass
7/10/19  
Refer
7/10/19  
Refer
7/10/19  
Refer
8/12/19  
Refer
8/12/19  
Report Pass
8/30/19  
Refer
9/10/19  
Refer
9/10/19  
Enrolled
9/12/19  
Enrolled
9/12/19  
Chaptered
10/12/19  
Chaptered
10/12/19  

Caption

Richard Paul Hemann Parkinson’s Disease Program.

Impact

The impact of AB 715 on state law includes prolonging the collection of epidemiological data and the reporting requirements placed on medical professionals regarding Parkinson's disease cases. This amendment helps safeguard the program's functions until January 1, 2021, allowing the state to respond effectively to this health issue. The legislation emphasizes the significance of consistent data gathering to inform future health policies and initiatives that may address the needs of patients suffering from Parkinson’s disease.

Summary

Assembly Bill 715 aims to extend the Richard Paul Hemann Parkinson’s Disease Program, which is crucial for monitoring and addressing Parkinson's disease in California. The bill allows the State Department of Public Health to continue collecting data on the incidence of Parkinson's disease, which is vital for understanding the disease's prevalence and for formulating appropriate public health strategies. By extending the program's existence, the state can maintain its focus on this chronic illness and ensure ongoing support for affected individuals and families.

Sentiment

The sentiment around AB 715 appears to be supportive, reflecting a collective acknowledgment of the importance of addressing chronic health conditions like Parkinson's disease. Consensus among lawmakers suggests that there is a shared understanding of the need to continue funding and supporting this health program. While specific opposition is not highlighted within the discussions, there remains an innate concern regarding the ongoing necessity of funding and resources for such programs, an issue prevalent in many public health discussions.

Contention

While there are no significant points of contention reported regarding AB 715, the challenge lies in the overall funding and sustainability of health programs like the Richard Paul Hemann Parkinson’s Disease Program. As this bill is set to extend reporting requirements and data collection, it inevitably calls into question the availability of adequate resources and support to maintain the program's objectives. Ultimately, the long-term future of the program may hinge on securing ongoing state funding and resources beyond the current extension set by this legislation.

Companion Bills

No companion bills found.

Similar Bills

CA AB2821

Richard Paul Hemann Parkinson’s Disease Program.

CA SB1442

Point-of-care tests for fentanyl.

CA ACR56

Parkinson’s Disease Awareness Month.

CA SCR43

Parkinson’s Disease Awareness Month.

CA SCR138

Parkinson’s Awareness Month.

CA AB829

Parkinson’s disease research grant program: Parkinson’s Disease Research Voluntary Tax Contribution Fund.

CA ACR36

Parkinson’s Disease Awareness Month.

CA ACR171

Parkinson’s Awareness Month.